Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Panita who wrote (10561)	12/15/1998 3:08:00 PM
From: Due Diligence	Read Replies (2) \| Respond to of 25711

(PR Wires) DJ: CYGS Confirms Appointments to Scientific Advisory Board DJ: CYGS Confirms Appointments to Scientific Advisory Board HOUSTON--(BUSINESS WIRE)--Dec. 15, 1998--Cryogenic Solutions Inc. (OTC BB:CYGS) announced formation of its Scientific Advisory Board to be chaired by Dr. Malcolm Skolnick, former member of the Board of Directors and currently of counsel to the company. In addition to Dr. Skolnick, the SAB membership includes Dr. Charles Conrad, Dr. Mark Emmett and Dr. Robert Roxby. Malcolm H. Skolnick, Ph.D., J.D. is Professor of Technology and Health Law at the School of Public Health in the University of Texas Health Sciences Center at Houston. Dr. Skolnick pursues research on policy issues at the interface of science and law. Charles A. Conrad, M.D. is Board Certified in Psychiatry and Neurology and is in private practice. He conducts research in molecular biology related to genetic factors in tumorogenesis and in anti-sense technology. Mark R. Emmett, Ph.D. is Associate Director and Director of Biological Applications of the Ion Cyclotron Resonance Center for Interdisciplinary Magnetic Resonance, National Magnetic Field Laboratory of Florida State University. Dr. Emmett's research centers on molecular biological applications in neurochemistry and neuropharmacology. Robert Roxby, Ph.D. is Research Director of the MidAmerica Neuroscience Research Foundation and formally Chairman of the Biochemistry Department of the University of Maine. Dr. Roxby's research has been focused on molecular biological applications including control of protein expression and isolation and enzymatic manipulation of DNA and RNA. The Scientific Advisory Board will review and critique protocols of sponsored research agreements, papers submitted for publication describing achieved research results, abstracts of presentations to be made at scientific and technical meetings, specifications and claims of patent applications and other matters where the company seeks scrutiny and verification of pertinent scientific/technical matters. Complete Curriculum Vitae of the members will be available on the CYGS website, www.biogenix.com. CONTACT: Cryogenic Solutions Inc., Houston Dell Gibson, 713/780-1399 14:36 EST DECEMBER 15, 1998 * end of story *